These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16608049)

  • 41. [Drug treatment for neuropathic pain].
    Attal N
    Presse Med; 2008 Feb; 37(2 Pt 2):346-53. PubMed ID: 18178057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [DRUG THERAPY OF NEUROPATHIC PAIN BASED ON THE LATEST RECOMMENDATIONS].
    Kiss G
    Ideggyogy Sz; 2015 Mar; 68(3-4):93-8. PubMed ID: 26434196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New perspectives on the management of diabetic peripheral neuropathic pain.
    Jensen TS; Backonja MM; Hernández Jiménez S; Tesfaye S; Valensi P; Ziegler D
    Diab Vasc Dis Res; 2006 Sep; 3(2):108-19. PubMed ID: 17058631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy.
    Sindrup SH; Holbech J; Demant D; Finnerup NB; Bach FW; Jensen TS
    Eur J Pain; 2017 Sep; 21(8):1443-1450. PubMed ID: 28557178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alleviation of pain in painful diabetic neuropathy.
    Tajti J; Szok D; Majláth Z; Csáti A; Petrovics-Balog A; Vécsei L
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):753-64. PubMed ID: 27149100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Painful diabetic peripheral neuropathy.
    Smith RG
    J Am Podiatr Med Assoc; 2007; 97(5):394-401. PubMed ID: 17901345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical aspects of pharmacological treatment of diabetic neuropathy - cooperation with neurologists and diabetologists].
    Janíčková Žďárská D; Kvapil M
    Vnitr Lek; 2016 Mar; 62(3):183-5. PubMed ID: 27180665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA; Hall J; Meyers AL; Gonzales J; Mallinckrodt C
    J Pain Symptom Manage; 2008 Dec; 36(6):639-47. PubMed ID: 18504092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profiles.
    Forde G
    J Fam Pract; 2007 Feb; 56(2 Suppl Pain):3-12. PubMed ID: 17270113
    [No Abstract]   [Full Text] [Related]  

  • 50. Interventions for Neuropathic Pain: An Overview of Systematic Reviews.
    Dosenovic S; Jelicic Kadic A; Miljanovic M; Biocic M; Boric K; Cavar M; Markovina N; Vucic K; Puljak L
    Anesth Analg; 2017 Aug; 125(2):643-652. PubMed ID: 28731977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-Term Outcomes in the Management of Painful Diabetic Neuropathy.
    Mai LM; Clark AJ; Gordon AS; Lynch ME; Morley-Forster PK; Nathan H; Smyth C; Stitt LW; Toth C; Ware MA; Moulin DE
    Can J Neurol Sci; 2017 Jul; 44(4):337-342. PubMed ID: 28065184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetic peripheral neuropathic pain. Consensus guidelines for treatment.
    J Fam Pract; 2006 Jun; Suppl():3-19. PubMed ID: 16838720
    [No Abstract]   [Full Text] [Related]  

  • 53. A study on comparative efficacy and cost effectiveness of Pregabalin and Duloxetine used in diabetic neuropathic pain.
    Roy MK; Kuriakose AS; Varma SK; Jacob LA; Beegum NJ
    Diabetes Metab Syndr; 2017; 11(1):31-35. PubMed ID: 27484440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review.
    Barrett AM; Lucero MA; Le T; Robinson RL; Dworkin RH; Chappell AS
    Pain Med; 2007 Sep; 8 Suppl 2():S50-62. PubMed ID: 17714116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic review of outpatient services for chronic pain control.
    McQuay HJ; Moore RA; Eccleston C; Morley S; Williams AC
    Health Technol Assess; 1997; 1(6):i-iv, 1-135. PubMed ID: 9483161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    Wu EQ; Birnbaum HG; Mareva MN; Le TK; Robinson RL; Rosen A; Gelwicks S
    J Pain; 2006 Jun; 7(6):399-407. PubMed ID: 16750796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Painful diabetic neuropathy: treatment and future aspects.
    Ziegler D
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S52-7. PubMed ID: 18395890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
    Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
    Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial effects of galanin system on diabetic peripheral neuropathic pain and its complications.
    Yu M; Fang P; Wang H; Shen G; Zhang Z; Tang Z
    Peptides; 2020 Dec; 134():170404. PubMed ID: 32898581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antidepressants for chronic neuropathic pain.
    Reisner L
    Curr Pain Headache Rep; 2003 Feb; 7(1):24-33. PubMed ID: 12525267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.